Literature DB >> 26117261

Stevens-Johnson syndrome and toxic epidermal necrolysis: the Food and Drug Administration adverse event reporting system, 2004-2013.

Junko Abe1, Kanako Mataki2, Ryogo Umetsu3, Natsumi Ueda3, Yamato Kato3, Yoko Nakayama3, Yasutomi Kinosada4, Hideaki Hara2, Naoki Inagaki5, Mitsuhiro Nakamura6.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26117261     DOI： 10.1016/j.alit.2015.01.002

Source DB:  PubMed          Journal:  Allergol Int        ISSN： 1323-8930            Impact factor:   5.836


× No keyword cloud information.
  9 in total

1.  Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System.

Authors:  Eric P Borrelli; Erica Y Lee; Andrew M Descoteaux; Stephen J Kogut; Aisling R Caffrey
Journal:  Epilepsia       Date:  2018-11-05       Impact factor: 5.864

2.  Culprit Medications and Risk Factors Associated with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case-Control Study.

Authors:  Naomi Gronich; David Maman; Nili Stein; Walid Saliba
Journal:  Am J Clin Dermatol       Date:  2022-02-04       Impact factor: 6.233

Review 3.  Drug induced exfoliative dermatitis: state of the art.

Authors:  Mona-Rita Yacoub; Alvise Berti; Corrado Campochiaro; Enrico Tombetti; Giuseppe Alvise Ramirez; Andrea Nico; Elisabetta Di Leo; Paola Fantini; Maria Grazia Sabbadini; Eustachio Nettis; Giselda Colombo
Journal:  Clin Mol Allergy       Date:  2016-08-22

4.  Analysis of polypharmacy effects in older patients using Japanese Adverse Drug Event Report database.

Authors:  Junko Abe; Ryogo Umetsu; Hiroaki Uranishi; Honami Suzuki; Yuri Nishibata; Yamato Kato; Natsumi Ueda; Sayaka Sasaoka; Haruna Hatahira; Yumi Motooka; Mayuko Masuta; Mitsuhiro Nakamura
Journal:  PLoS One       Date:  2017-12-21       Impact factor: 3.240

5.  Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.

Authors:  Shiori Hasegawa; Toshinobu Matsui; Yuuki Hane; Junko Abe; Haruna Hatahira; Yumi Motooka; Sayaka Sasaoka; Akiho Fukuda; Misa Naganuma; Kouseki Hirade; Yukiko Takahashi; Yasutomi Kinosada; Mitsuhiro Nakamura
Journal:  PLoS One       Date:  2017-07-21       Impact factor: 3.240

6.  Assessment of Reye's syndrome profile with data from the US Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases using the disproportionality analysis.

Authors:  Kiyoka Matsumoto; Shiori Hasegawa; Satoshi Nakao; Kazuyo Shimada; Ririka Mukai; Mizuki Tanaka; Riko Satake; Yu Yoshida; Fumiya Goto; Misaki Inoue; Hiroaki Ikesue; Kazuhiro Iguchi; Tohru Hashida; Mitsuhiro Nakamura
Journal:  SAGE Open Med       Date:  2020-11-20

7.  Acetaminophen-induced Stevens-Johnson syndrome with lethal lung injury: A case report.

Authors:  Ryota Nakamura; Fumihiro Ochi; Toshiyuki Chisaka; Toshihiro Jogamoto; Mariko Eguchi
Journal:  Clin Case Rep       Date:  2022-09-05

8.  Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020.

Authors:  Liqin Wang; Sheril Varghese; Fatima Bassir; Ying-Chin Lo; Carlos A Ortega; Sonam Shah; Kimberly G Blumenthal; Elizabeth J Phillips; Li Zhou
Journal:  Front Med (Lausanne)       Date:  2022-08-24

9.  Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis using the Japanese Adverse Drug Event Report database.

Authors:  Junko Abe; Ryogo Umetsu; Kanako Mataki; Yamato Kato; Natsumi Ueda; Yoko Nakayama; Yuuki Hane; Toshinobu Matsui; Haruna Hatahira; Sayaka Sasaoka; Yumi Motooka; Hideaki Hara; Zenichiro Kato; Yasutomi Kinosada; Naoki Inagaki; Mitsuhiro Nakamura
Journal:  J Pharm Health Care Sci       Date:  2016-06-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.